TCF7L2 and metabolic dysfunction-associated steatotic liver disease: Pathologically, hepatic Tcf7l2 deficiency-induced fatty liver progressed to NASH, a severe form of NAFLD, demonstrating the potent effect of TCF7L2 on hepatic DNL.